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The resolution of racemic corycavine via its (-f)-lO-camphorsulfonate, the 
equivalency of (+)-corycavine and corycavamine, as well as the racemization 
of (+)-corycavine are described. 13/?-Configuration is assigned to (+)-cory-
cavine, based on CD data. 
Chiroptische Eigenschaften von (+)-Corycavin und Corycavamln 
Die Enantiomerentrennung von razemischem Corycavin über das (+)-10-
Kampfersulfonat, die Identität von (+>-Corycavin mit Corycavamin und die 
Razemisierung von (+)-Corycavin werden beschrieben. Aufgrund von CD-
Messungen wird (+)-Corycavin 13/?-Konfiguration zugeordnet 
Corycavine (1) and corycavamine ' (Scheme 1) were isolated from 
Corydalis cava (tuberosa), papaveraceae, in 1894 and 1902, respectively. 
The structure of these alkaloids was proposed by von Bruckhausen3* in 
1925 as 1, indicating that these compounds are protopine type alkaloids4*. 
V. Bruckhausen^ termed the optically inactive form, m.p. 217-218°C cory-
cavine (1), while the optically active form with a specific rotation of 
+166.6° (m.p. 148-149°C) is termed corycavamine (2). 
Crystallographic data presented in our previous paper5* 
demonstrated that corycavine (1) exactly fits the "racemic 
form". Several reports6) concerning the isolation of (±)-co-
rycavine (1) have been described. However, since Ga-
damer's description, we have not seen lit. regarding the iso-
lation of corycavamine (2). In general, it seems relatively 
unique for naturally occurring alkaloids bearing an asymme-
tric C-atom to be isolated as a racemate only. Further, the 
lit. cited above3* also described racemization occurring from 
heating with acetic anhydride at above 180°C. One can, 
therefore, presume that corycavamine (2) converts to (±)-
corycavine (1) relatively easily through usual isolation treat-
ment. 
In biosynthesis, protopine type alkaloids are key inter-
mediate to benzo[c]phenanthridine type (sanguinarine, etc.), 
and to hydrobenzo[c]phenanthridine type (corynoline and 
chelidonine, etc.), having pharmacological significance7*. 
The relationship between the absolute configurations of 
both types tells us what kind of enzymatic reaction mechan-
ism takes place at the ring reconstitution stage. Thus, it 
seemed important to investigate further the absolute con-
figuration and chiroptical properties of protopine type alka-
loids. 
The present paper deals with the optical resolution of (±)-
corycavine (1), and the measurement of racemization of (+)-
corycavine (2), by the circular dichroism (CD) method and 
by ]H-NMR spectroscopy, as well as a consideration of the 
absolute configuration of (+)-corycavine (2) and its deriva-
tives by CD. 
Optical Resolution of 1 and Identification with 
Corycavamine 
The resolution of racemic corycavine (1) is important for 
comparison with the optically active corycavamine (2), for 
which data are available8*. 
(±)-Corycavine (1) was isolated from Corydalis incisa, 
papaveraceae, and optical resolution of 1 with (+)-10-cam-
phorsulfonic acid was carried out by fractional crystal-
lization of the diastereomeric salts. At first, transparent 
plates m.p. 282-287°C separated which were transformed to 
the optically active (-)-corycavine (3) as free base, colorless 
needles, m.p. 145-148°C, [ot]D -170°. The optical isomer 
was obtained in the same manner from the mother liquor 
after successive recrystallization. The diastereomeric salt, 
transparent needles, m.p. 275-276°C, gave the optically ac-
tive enantiomeric base (+)-corycavine (2), colorless needles, 
m.p. 145-146°C, [a]D +172°. 100% optical purities of each 
(+)- and (-)-corycavine (2 and 3) were confirmed as fol-
lows: 1) The numerical values of the melting points and the 
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Fig. 1 The rate of racemization of 3. Residual [9] intensity % = [6]-value at 
x min after/initial [0]-value X 100. 
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specific optical rotation of 2 and 3 were not altered by re-
crystallization. 2) The ER-spectrum of 2 in KBr substantially 
agreed with the spectrum of 3, but did not agree with the 
spectrum of 1. All three spectra agreed in solution. 3) The 
CD-spectra of 2 and 3 are also equal in intensity though 
opposite in sign. Melting point, crystal form, specific optical 
rotation, etc. of 2 prepared in this way agreed very closely 
with those of corycavamine described by Godamed. Con-
sequently, one can conclude that corycavamine is identical 
with (+)-corycavine (2) with 100% optical purity. 
Measurements of Racemization of 2 and 3 
The chiral center C-13 in 2 is located in the a-position of 
the keto group and in benzyl-position. Consequently, 
racemization of 2 is believed to be relatively easy. In order 
to study this racemization, the rate was investigated under 
alkaline conditions generally used for isolation of alkaloids 
from various plants. 
The time-course of CD-band intensities at 286 nm of 3 
was measured in ethanolic NaOH at 20°C. The rate of re-
maining optical activity of 3 was calculated by use of the 
value [8] at 286 nm, and the slope for the data was deter-
mined by the least-squares method (Fig. 1). The rate of 
racemization of 3 was 5.96 x 10"2 min"1 and the half-life 
period was 11.6 min. The similarity of this value to that of 
(-)-1,2-dipheny 1-propan-1 -one9* suggests that the racemiza-
tion rate of 3 is due to its having in part the same structure. 
From the *H-NMR results, furthermore, we elicited infor-
mation about the racemization of 2. All proton resonances 
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Fig. 2 *H-NMR spectra of 2 in CDC13 at 27°C. (a) Spectrum of 2. (b) 
Addition of NaOD in CD 3 OD and delay of several min. (c) Addition of 
NaOD in CD 3 OD and delay of 3 h. 
in CDC13 have been assigned5*. The spectrum (Fig. 2a) dis-
played the methyl protons (C-13H-CH3) as a doublet with J 
= 7 Hz at 8 = 1.36. By addition of NaOD in CD 3 OD this 
doublet collapsed to a singlet at 8 = 1.36 (spectrum b); after 
3 h, the spectrum c showed only the deuterated species. 
This phenomenon is due to the disappearance of the proton 
coupling (C-13D-CH3). The !H-NMR spectra indicate that 
the asymmetric carbon atom C-13 of 2 bears a readily ioniz-
able hydrogen atom which exchanges easily H against D. 
These results show that optically active 13-substituted 
protopine type alkaloids are rapidly converted into race-
mates under mild alkaline conditions. This suggests that, if 
isolation from plants is meticulously carried out, the opti-
cally active form in the corycavine/corycavamine fraction 
may be obtained. The isolation of naturally occurring 2 
from Corydalis incisa and Corydalis cava was studied 
again. The examination showed that 2 comprises 60% in the 
1 and 2 fraction from Corydalis incisa and 14% from C. 
cava plants. 
Relationship between CD-Spectra and the Absolute 
Configuration of 2 and its Derivatives 
The CD-spectrum of 2 is of interest in connection with the 
absolute configuration of the asymmetric C-13 atom. While 
the ORD- and CD-spectral investigation of protoberberine 
type alkaloids has been reported in several papers10*, no 
study has been reported on the chiroptical discussion of 
protopine type. Earlier work5* had shown that for 1, in spite 
of a ten-membered ring system with one rigid conformation 
in solution, direct use of the empirically CD-spectral rule 
derived from protoberberine type compounds for coryca-
vine was problematic. Consequently, 2 was converted into a 
protoberberine by reductive ring closure, and the CD-spec-
trum of that derivative was also investigated. 
The protopine skeleton of (+)-corycavine was transformed 
to a protoberberine skeleton as follows (Scheme 1): Reduc-
tion of 2 with UAIH4 gave the optically active (+)-dihydro-
Fig. 3 CD spectra of 2,3, and 4 in MeOH. — 2 — 3 — 4. 
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corycavine (4). 4 was treated with aqu. HCl, followed by aromatic chromophobe. Accordingly, a remarkable reduc-
addition of KJ. The ring closure product was identical with tion in the magnitude of the 290 nm absorption for 4, com-
(+)-mejcMerahydrocorysamine N-methiodide (5). pared with 2 and 3, is attributable to the disappearance of 
Scheme 1 
The CD-spectra of 2, 3, and 4 are shown in Fig. 3. The 
curve for 2 shows from the side of the long wave length 
positive and negative maxima in a-band (at around 290 
nm), in p-band (at» 240 nm) and in ß-band (a t« 200 nm). 
The curve of 3 is the mirror-image of 2. A striking charac-
teristic of the spectra of 2 and 3 is the high amplitude of the 
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Fig. 4 Newman projection (C(13) -> C(14)) of 1. 
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Fig. 5 CD spectra of 5 and salt of 2 in MeOH.—5 — Trifluoroacetate of 2. 
the C=0 group, now converted into the OH-group. In addi-
tion, the remarkable reduction in the magnitude of the Cot-
ton effect near 200 nm in 4 may be attributed to the confor-
mational change of ring B, due to the flexibility of this 
ten-membered ring. 
It is known11} that protonation of protopine type alkaloids 
leads to a quaternary form similar to the quaternary meth-
iodides of protoberberine type alkaloids. The preferred con-
formation of the salt of 2 may be the cfr-quinolizidine sys-
tem, in order to avoid the stcric hindrance between the C-
13-methyl group and the two protons at C- l and C-12. This 
is also confirmed by the NMR studyl2). The CD-spectra of 
the TFA salt of 2 and 5 are shown in Fig. 5. Each compound 
has two asymmetric carbons and an asymmetric N-atom and 
they differ only in the substituent at C-l3a. Both curves 
have intrinsically similar CD properties. From a consider-
ation of the whole spectral pattern and from a comparison 
of the CD data with that of other protoberberine type alka-
loids10), it seems most reasonable to conclude that the abso-
lute configuration of the salt of 2 must be assigned as 
7N(/?),13(tf),andl3a(S). 
Therefore, the absolute configuration of 2-base must be 
assigned as 13(A). 
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Experimental Part 
General Remarks 
Melting points: Kotier hot stage apparatus, uncorrected.- IR spectra: 
EPI-C2 (Hitachi), nujol, KBr pellets, CHC13 solution.- Mass spectra: 
JEOL-DIS.- *H-NMR spectra: Varian-XL-200 (200 MHz, FT-mode), TMS 
as interna] standard. Coupling constants J in Hz.- Optical rotations: DIP-SL 
(JASCO) Polarimeter.- CD spectra: ORD/UV-5 and CD-J-500C (JASCO), 
data were measured at ca. 3 x 10"4 mol/I at 20°C in cells of 0.1-5 mm path 
lengths. 
290 nm Cotton effects. As indicated in Fig. 4, which shows 
the Newman projection (C-l3 -> C-l4) of 1 as revealed by 
X-ray analysis5*, they may be influenced by the n-n transi-
tion of the carbonyl group upon the n-n transition of the 
/. Optical resolution of(±)-corycavine (1) 
To a solution of 1 (157 mg) in methanol was added a solution of (+)-
camphorsulfonic acid (100 mg) in methanol. After removal of the solvent, 
the remaining residue gave the (±)-corycavine (+)-camphorsulfonatae, m.p. 
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273-275°C The salt was recrystaliized from a mixed solvent (methanol, 
acetone, ether) three times for 12 h at room temp, to give (-)-corycavine 
(+)-camphorsulfonate (40 mg) as colorless plates. m.p. 282-287*0. The 
crystals were dissolved in H2O (50 ml). The aqueous solution was made 
faintly alkaline to litmus with 5% NH3/H2O and extracted rapidly with 
ether (2 x 20 ml). The org. phase was washed with saturated NaG solution 
(2 x 20 ml), dried with Na 2 S0 4 and evaporated in vacuo. The residue was 
crystallized from ether/petroleum ether to give 24 mg of (-)-corycavine: 
transparent needles, m.p. 145-146°C- [afi -170.0° (c » 1.3, CHC13).-
C21H21O3N (367.1) Calcd. C 68.6 H 5.76 N 3.8 Found C 68.5 H 5.84 N 
4.0.- IR: v max (Nujol) 1665 cm*1.- EIMS: 367 (M**: 4), 281 (4). 204 (8), 
162 (100).- CD (MeOH) A e (nm): +0.08 (320), -1.74 (301), +3.55 (281.5), 
-0.21 (257), +8.70 (230), -21.09 (207).- *H-NMR (CDC13): 5 (ppm) = 7.02 
(1H, s, H-l), 6.87 (1H, d, J • 8.5 Hz, H-12), 6.81 (1H, d, J « 8.5 Hz, H-l 1), 
6.67 (1H, s, H-4), 6.01, 5.98 (2H, 2d, J = 1.0 Hz, 0-CH 2-0), 5.96 (2H, s, 
O-CH2-O), 4.26 (1H, q, J « 7.3 Hz, H-13), 3.85, 3.50 (each 1H, d, J = 14 
Hz, H-8), 3.45,2.56 (each 1H, m, H-5), 2.89,2.30 (each 1H, m, H-6), 1.83 
(3H, s, N-CH 3), 1.36 (3H, d, J * 7.3 Hz, C-CH 3). 
The mother liquor was evaporated, and the residue gave (+)-corycavine 
(+)-10-camphorsulfonate as colorless needles (25 mg, m.p. 274-276°C) 
after 3 successive recrystallizations from a mixed solvent (MeOH, acetone, 
ether). The salt was treated according to the above procedure for (-)-cory-
cavine salt, to afford 14 mg of (+)-corycavine with ether/petroleum ether, 
transparent needles, m.p. 145-146°C- [a]% +172.0° (c = 1.0, CHC13).-
C21H21O5N (367.1) Calcd. C 68.6 H 5.76 N 3.8 Found C 68.5 H 5.81 N 
4.O.- IR: v max (Nujol) 1665 cm"1.- EIMS: 367 (M4"), 281,204,162.- CD 
(MeOH) A e (nm): -0.10 (320), +1.78 (300), -3.70 (281), +8.28 (256), -7.86 
(230), +21.21 (207).- CD (McOH+CF3COOH): -0.31 (297.5), +0.93 (280), 
+6.64 (243), -1.10 (224), +54.93 (209), -11.88 (197). 
2. Isolation of 1 and 2 from Corydalis cava and C. incisa 
The plants (70 g, dry weight) were soaked in MeOH (3 x 500 ml) at 
room temp, for 24 h, then the mixture was filtered. The extracts were 
combined and evaporated in vacuo. The residue was extracted with tartaric 
acid (3%, 300 ml). This acid layer was washed with ether (2 x 150 ml) and 
its pH adjusted to 7.5 (5% aqueous NH 3). The alkaline solution was imme-
diately extracted with ether (2 x 200 ml) and the combined ether layer was 
dried (K 2 C0 3 ) and evaporated to give an oil. The oil was chromatographed 
by prep. TLC (Si0 2; benzene:ether = 1:1; elution CHC13) to yield the 
mixture of 1 + 2 (Rf = 0.26) as an oil. 1/2-Fraction from C. cava: 2.8 mg, 
[apo +24.0° (c » 0.2, CHC13). 1/2-Fraction from C. incisa: 5.9 mg, [afi 
+102.5° (c = 0.5, CHC13). 
3. Preparation of (+)-Dihydrocorycavine (4) 
To 2 (20 mg) in absol. benzene, LiAJH 4 (10 mg) in absol. Et 2 0 was 
added slowly drop by drop with stirring under N 2 at room temp. After 
keeping for 2 h, H 2 S 0 4 (10%, 10 ml) and NaOH (10%, 60 ml) were 
successively added to the reaction mixture. The resulting solution was ex-
tracted with ether (2 x 50 ml). The ether layer was washed with saturated 
NaCl-solution, dried (K 2 C0 3 ) , and evaporated to give (+)-4 (6.7 mg). Re-
crystallization from methanol gave colorless columns, m.p. 219-220°C-
[a}2o +43.0° (c = 0.7, CHC13).- IR: v max (KBr) = 3420; 3100 cm"1.-
EIMS: 369 (M*\ 3), 206 (16), 163 (31), 162 (100).- C21H2P5N (369.1) 
Calcd. C 68.3 H 6.28 N 3.8 Found C 68.2 H 6.27 N 3.8.- CD MeOH A e 
(nm): -0.14 (299), +0.39 (280), +9.02 (248), -3.27 (227), +4.90 (210), 
-12.09 (201). (CH3CN) -0.48 (229), +0.47 (282), +9.01 (250), -4.07 (230), 
+4.00 (211), -19.3 (202).- !H-NMR (CDC13 at 60°C): 8 (ppm) * 7.75 (1H, 
m, C-13-OH), 6.92 (1H, d. J = 8.0 Hz, H-12), 6.78 (1H, d, J = 8.0 Hz, 
H-U), 6.73 (1H, s, H-l), 6.62 (1H, s, H-4), 5.93 (4H, s, 2 x 0-CH 2-0), 
4.36 (1H, m, H-14), 3.66 (2H, dd, J » 14.0 and 18.0 Hz, H-8), 3.56 (1H, m, 
H-13), 3.02 (4H, m, H-5 and H-6), 2.35 (3H, s, N-CH 3), 1.34 (3H, d, J = 
7.0Hz.C-CH 3). 
4. (+)-MesotetrahydrocorysamineN-methiodide (5) 
To (+)-4 (46 mg), HCl (20%, 0.5 ml) was added, and the mixture was 
heated on a water bath for 4 h. After cooling, H 2 0 (5 ml) was added. To 
the solution, a saturated solution of KI was added in drops until no more 
precipitation was observed. The precipitate was collected with filtration 
and then dissolved in methanol and applied to a A1 2 0 3 column chromato-
graphy (MeOH). Recrystallization from methanol afforded 13 mg of (+)-5 
as colorless prisms, m.p. 240-250°C- [ a ] 2 ^ +192° (c = 0.8, MeOH).-
C21H22O4NI (479.3) Calcd. C 52.6 H 4.63 N 2.9 Found C 52.5 H 4.58 N 
2.9.- CD MeOH A e (nm): -0.11 (302), +1.21 (283), +7.94 (242), +65.2 
(209). 
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